Peer-reviewed veterinary case report
Canine indolent lymphoma types and behavior explained
By Valli, V. E. et al.·Published in Veterinary and Comparative Oncology·2004·View original on Crossref →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Clonality and clinical behavior of canine indolent lymphoma
- Species:
- dog
Plain-English summary
A group of dogs diagnosed with indolent lymphoma, a type of cancer that grows slowly, were studied to understand their survival and treatment outcomes. Most of the cases were B-cell types, and many dogs lived for an average of 18.8 months after diagnosis, often dying from unrelated causes rather than the lymphoma itself. In one case, a dog was euthanized at the owner's request while still healthy, and another was lost to follow-up. This suggests that many dogs with this type of lymphoma can have a good quality of life for a significant time after diagnosis.
People also search for: dog lymphoma survival rate · indolent lymphoma in dogs · treatment options for dog lymphoma · signs of lymphoma in dogs · dog cancer prognosis
Abstract
Introduction: Canine lymphomas with a follicular architecture are biologically indolent and include follicular (FL), mantle cell (MCL), marginal zone (MZL) and T‐zone (TZL) types. They are under recognized and have long survival regardless of treatment.Methods: 70 cases of canine lymphoma with fading follicular hyperplasia (FFH) received1 over 1996 to present were reviewed. Diagnoses were determined by consensus of three pathologists1,2 on phenotyped tissues. Clonality for B and T‐cell receptor genes was determined on DNA from paraffin blocks via PCR on 53 of 70 cases2.Results: Of the total of 70 cases 52 were of B‐cell type (MZL 44, FL 4, MCL 3, MALT 1) and 9 were of T‐cell type (TZL). 9 cases of benign hyperplasia were included to assist in defining the histologic boundaries of neoplasia. Case presentation included splenic 16, and nodal 54. For 44 cases called MZL on histologic criteria, DNA was available on 33 of which 26 (78.8%) were clonal for B‐cell rearranged gene including 5 also clonal for T‐cell receptor, one clonal for T‐cell only and 6 cases negative for both and considered benign. For TZL, DNA was available on 6 of 9 cases of which 3 were clonal for T‐cell receptor, 1 for B‐cell, 1 for both and 2 polyclonal for both.Conclusions: An Ohio review of 380 cases of canine nodal lymphoma found 29% of cases to be of indolent type as described here and thus a very significant part of the patient population. Seven of 10 cases of MZL treated at Illinois with follow‐up died of other causes than lymphoma at an average of 18.8 months after diagnosis. One of the other three was lost to follow‐up, one was euthanized at owners’ choice at 9.5 m. after diagnosis still in good health and the other was terminated 3 m after diagnosis with concurrent lung carcinoma.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on Crossref: https://doi.org/10.1111/j.1476-5810.2004.0045r.x